CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 144 Insider Sale of Securities
- 8-K Event Results of operations · Other events
- 8-K Event Material agreement
- 4 Shares withheld for taxes 10% owner gave up 1 shares (to pay taxes)
- 4 Open-market sale President and CEO sold 2,915 shares at an average $13.19 ($38,437)
- 4 Open-market sale Chief Accounting Officer sold 1,804 shares at an average $13.19 ($23,788)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Exit or restructuring costs
- 8-K Event Executive or director change
- 4 Open-market sale President and CEO sold 2,958 shares at an average $11.62 ($34,360)
- 4 Open-market sale Chief Accounting Officer sold 1,809 shares at an average $11.61 ($21,009)
- 4 Open-market buy 10% owner bought 55,000 shares at $12.19 ($670,423)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 4 of 57 · 1,133 filings